CCAAT/Enhancer binding protein d in macrophages contributes to immunosuppression and inhibits phagocytosis in nasopharyngeal carcinoma

Science Signaling

Volumn 6, Issue 284, 2013, Pages

  Hsiao, Yu Wei ^a   Li, Chien Feng ^b   Chi, Jhih Ying ^a   Tseng, Joseph T ^a   Chang, Yao ^c   Hsu, Li Jin ^a   Lee, Chien Hsun ^c   Chang, Tsung Hao ^a   Wang, Shao Ming ^a   Wang, Dennis Ding Hwa ^d   Cheng, Hung Chi ^a   Wang, Ju Ming ^a,e  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN DELTA; DACTINOMYCIN; HU ANTIGEN; HUR PROTEIN; INTERLEUKIN 10; MESSENGER RNA; PENTRAXIN 3; PROSTAGLANDIN E2; TOSYLARGININE METHYL ESTER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL PHAGOCYTOSIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG INHIBITION; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; MACROPHAGE; MALE; MOUSE; NASOPHARYNX CARCINOMA; NONHUMAN; NUCLEOCYTOPLASMIC TRANSPORT; PRIORITY JOURNAL; RNA STABILITY;

C-REACTIVE PROTEIN; CCAAT-ENHANCER-BINDING PROTEIN-DELTA; DINOPROSTONE; HU PARANEOPLASTIC ENCEPHALOMYELITIS ANTIGENS; HUMANS; IMMUNE TOLERANCE; INTERLEUKIN-10; MACROPHAGES; NASOPHARYNGEAL NEOPLASMS; PHAGOCYTOSIS; RNA STABILITY; RNA, MESSENGER; SERUM AMYLOID P-COMPONENT; U937 CELLS;

EID: 84880868221     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003648     Document Type: Article

References (42)

1. J. W. Pollard, Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4, 71-78 (2004). (Pubitemid 38082155)
2. S. C. Gupta, J. H. Kim, S. Prasad, B. B. Aggarwal, Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29, 405-434 (2010).
3. 2 inhibits CCL5 production in activated macrophages through cAMP/PKA signaling pathway. J. Biol. Chem. 286, 2111-2120 (2011).
4. M. Yao, K. Ohshima, J. Suzumiya, T. Kume, T. Shiroshita, M. Kikuchi, Interleukin-10 expression and cytotoxic-T-cell response in Epstein-Barr-virus- associated nasopharyngeal carcinoma. Int. J. Cancer 72, 398-402 (1997). (Pubitemid 27325864)
5. J. W. Tjiu, J. S. Chen, C. T. Shun, S. J. Lin, Y. H. Liao, C. Y. Chu, T. F. Tsai, H. C. Chiu, Y. S. Dai, H. Inoue, P. C. Yang, M. L. Kuo, S. H. Jee, Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction. J. Invest. Dermatol. 129, 1016-1025 (2009).
6. A. Puig-Kröger, E. Sierra-Filardi, A. Domínguez-Soto, R. Samaniego, M. T. Corcuera, F. Gómez-Aguado, M. Ratnam, P. Sánchez-Mateos, A. L. Corbí, Folate receptor b is expressed by tumor-associated macrophages and constitutes a marker for M2 anti-inflammatory/regulatory macrophages. Cancer Res. 69, 9395-9403 (2009).
7. C. H. Lee, T. H. Yeh, H. C. Lai, S. Y. Wu, I. J. Su, K. Takada, Y. Chang, Epstein-Barr virus Zta-induced immunomodulators from nasopharyngeal carcinoma cells upregu-late interleukin-10 production from monocytes. J. Virol. 85, 7333-7342 (2011).
8. R. de Waal Malefyt, J. Haanen, H. Spits, M. G. Roncarolo, A. te Velde, C. Figdor, K. Johnson, R. Kastelein, H. Yssel, J. E. de Vries, Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J. Exp. Med. 174, 915-924 (1991).
9. C. M. Brennan, J. A. Steitz, HuR and mRNA stability. Cell. Mol. Life Sci. 58, 266-277 (2001). (Pubitemid 32217358)
10. M. Nguyen-Chi, D. Morello, Aberrant regulation of mRNA 3? untranslated region in cancers and inflammation. Med. Sci. 24, 290-296 (2008). (Pubitemid 351427512)
11. A. Doller, J. Pfeilschifter, W. Eberhardt, Signalling pathways regulating nucleo-cytoplasmic shuttling of the mRNA-binding protein HuR. Cell. Signal. 20, 2165-2173 (2008).
12. X. C. Fan, J. A. Steitz, HNS, a nuclear-cytoplasmic shuttling sequence in HuR. Proc. Natl. Acad. Sci. U.S.A. 95, 15293-15298 (1998). (Pubitemid 29018692)
13. Z. Yuan, A. J. Sanders, L. Ye, Y. Wang, W. G. Jiang, Knockdown of human antigen R reduces the growth and invasion of breast cancer cells in vitro and affects expression of cyclin D1 and MMP-9. Oncol. Rep. 26, 237-245 (2011).
14. N. Embade, D. Fernández-Ramos, M. Varela-Rey, N. Beraza, M. Sini, V. Gutiérrez de Juan, A. Woodhoo, N. Martínez-López, B. Rodríguez-Iruretagoyena, F. J. Bustamante, A. B. de la Hoz, A. Carracedo, D. P. Xirodimas, M. S. Rodríguez, S. C. Lu, J. M. Mato, M. L. Martínez-Chantar, Murine double minute 2 regulates Hu antigen R stability in human liver and colon cancer through NEDDylation. Hepatology 55, 1237-1248 (2012).
15. G. J. Nau, J. F. Richmond, A. Schlesinger, E. G. Jennings, E. S. Lander, R. A. Young, Human macrophage activation programs induced by bacterial pathogens. Proc. Natl. Acad. Sci. U.S.A. 99, 1503-1508 (2002). (Pubitemid 34136522)
16. 2-dependent transactivation of insulin-like growth factor I gene expression in rat osteo-blasts. Mol. Endocrinol. 17, 1834-1843 (2003). (Pubitemid 37072299)
17. Y. Sato, Y. Nishio, O. Sekine, K. Kodama, Y. Nagai, T. Nakamura, H. Maegawa, A. Kashiwagi, Increased expression of CCAAT/enhancer binding protein-b and -d and monocyte chemo-attractant protein-1 genes in aortas from hyperinsulinaemic rats. Diabetologia 50, 481-489 (2007).
18. C. Y. Ko, H. C. Hsu, M. R. Shen, W. C. Chang, J. M. Wang, Epigenetic silencing of CCAAT/enhancer-binding protein d activity by YY1/polycomb group/DNA methyltransferase complex. J. Biol. Chem. 283, 30919-30932 (2008).
19. S. R. Wu, C. F. Li, L. Y. Hung, A. M. Huang, J. T. Tseng, J. H. Tsou, J. M. Wang, CCAAT/enhancer-binding protein d mediates tumor necrosis factor a-induced Aurora kinase C transcription and promotes genomic instability. J. Biol. Chem. 286, 28662-28670 (2011).
20. K. Balamurugan, J. M. Wang, H. H. Tsai, S. Sharan, M. Anver, R. Leighty, E. Sterneck, The tumour suppressor C/EBPd inhibits FBXW7 expression and promotes mammary tumour metastasis. EMBO J. 29, 4106-4117 (2010).
21. Y. W. Liu, H. P. Tseng, L. C. Chen, B. K. Chen, W. C. Chang, Functional cooperation of simian virus 40 promoter factor 1 and CCAAT/enhancer-binding protein b and d in lipopolysaccharide-induced gene activation of IL-10 in mouse macrophages. J. Immunol. 171, 821-828 (2003).
22. J. Yi, N. Chang, X. Liu, G. Guo, L. Xue, T. Tong, M. Gorospe, W. Wang, Reduced nuclear export of HuR mRNA by HuR is linked to the loss of HuR in replicative senescence. Nucleic Acids Res. 38, 1547-1558 (2010).
23. H. Liao, M. C. Hyman, A. E. Baek, K. Fukase, D. J. Pinsky, cAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohydrolase 1 (CD39) expression. J. Biol. Chem. 285, 14791-14805 (2010).
24. B. T. Chiang, Y. W. Liu, B. K. Chen, J. M. Wang, W. C. Chang, Direct interaction of C/EBPd and Sp1 at the GC-enriched promoter region synergizes the IL-10 gene transcription in mouse macrophage. J. Biomed. Sci. 13, 621-635 (2006).
25. C. Y. Ko, L. H. Chang, Y. C. Lee, E. Sterneck, C. P. Cheng, S. H. Chen, A. M. Huang, J. T. Tseng, J. M. Wang, CCAAT/enhancer binding protein delta (CEBPD) elevating PTX3 expression inhibits macrophage-mediated phagocytosis of dying neuron cells. Neurobiol. Aging 33, 422.e11-422.e25 (2012).
26. B. Thomas, F. Berenbaum, L. Humbert, H. Bian, G. Béréziat, L. Crofford, J. L. Olivier, Critical role of C/EBPd and C/EBPb factors in the stimulation of the cyclooxygenase-2 gene transcription by interleukin-1b in articular chondrocytes. Eur. J. Biochem. 267, 6798-6809 (2000).
27. W. L. Wang, Y. C. Lee, W. M. Yang, W. C. Chang, J. M. Wang, Sumoylation of LAP1 is involved in the HDAC4-mediated repression of COX-2 transcription. Nucleic Acids Res. 36, 6066-6079 (2008).
28. K. Nishioka, S. Ohshima, M. Umeshita-Sasai, N. Yamaguchi, T. Mima, S. Nomura, N. Murata, M. Shimizu, T. Miyake, K. Yoshizaki, M. Suemura, T. Kishimoto, Y. Saeki, Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPb and C/EBPd, in rheumatoid synovium. Arthritis Rheum. 43, 1591-1596 (2000). (Pubitemid 30452480)
29. P. Rovere, G. Peri, F. Fazzini, B. Bottazzi, A. Doni, A. Bondanza, V. S. Zimmermann, C. Garlanda, U. Fascio, M. G. Sabbadini, C. Rugarli, A. Mantovani, A. A. Manfredi, The long pentraxin PTX3 binds to apoptotic cells and regulates their clearance by antigen-presenting dendritic cells. Blood 96, 4300-4306 (2000).
30. J. Fan, N. M. Heller, M. Gorospe, U. Atasoy, C. Stellato, The role of post-transcriptional regulation in chemokine gene expression in inflammation and allergy. Eur. Respir. J. 26, 933-947 (2005). (Pubitemid 41632053)
31. S. K. Basu, R. Malik, C. J. Huggins, S. Lee, T. Sebastian, K. Sakchaisri, O. A. Quinones, W. G. Alvord, P. F. Johnson, 3'UTR elements inhibit Ras-induced C/EBPb post-translational activation and senescence in tumour cells. EMBO J. 30, 3714-3728 (2011).
32. S. Galbán, Y. Kuwano, R. Pullmann Jr., J. L. Martindale, H. H. Kim, A. Lal, K. Abdelmohsen, X. Yang, Y. Dang, J. O. Liu, S. M. Lewis, M. Holcik, M. Gorospe, RNA-binding proteins HuR and PTB promote the translation of hypoxia-inducible factor 1a. Mol. Cell. Biol. 28, 93-107 (2008).
33. M. D. Díaz-Muñoz, I. C. Osma-García, M. Fresno, M. A. Iñiguez, Involvement of PGE2 and the cAMP signalling pathway in the up-regulation of COX-2 and mPGES-1 expression in LPS-activated macrophages. Biochem. J. 443, 451-461 (2012).
34. V. W. Tsai, M. G. Mohammad, O. Tolhurst, S. N. Breit, P. E. Sawchenko, D. A. Brown, CCAAT/enhancer binding protein-d expression by dendritic cells regulates CNS autoimmune inflammatory disease. J. Neurosci. 31, 17612-17621 (2011).
35. P. Baruah, I. E. Dumitriu, G. Peri, V. Russo, A. Mantovani, A. A. Manfredi, P. Rovere-Querini, The tissue pentraxin PTX3 limits C1q-mediated complement activation and phagocytosis of apoptotic cells by dendritic cells. J. Leukoc. Biol. 80, 87-95 (2006). (Pubitemid 44835529)
36. J. J. Chen, Y. C. Lin, P. L. Yao, A. Yuan, H. Y. Chen, C. T. Shun, M. F. Tsai, C. H. Chen, P. C. Yang, Tumor-associated macrophages: The double-edged sword in cancer progression. J. Clin. Oncol. 23, 953-964 (2005). (Pubitemid 46202315)
37. P. Kaler, V. Galea, L. Augenlicht, L. Klampfer, Tumor associated macrophages protect colon cancer cells from TRAIL-induced apoptosis through IL-1b-dependent stabilization of Snail in tumor cells. PLoS One 5, e11700 (2010).
38. Y. C. Pan, C. F. Li, C. Y. Ko, M. H. Pan, P. J. Chen, J. T. Tseng, W. C. Wu, W. C. Chang, A. M. Huang, E. Sterneck, J. M. Wang, CEBPD reverses RB/E2F1-mediated gene repression and participates in HMDB-induced apoptosis of cancer cells. Clin. Cancer Res. 16, 5770-5780 (2010).
39. T. C. Hour, Y. L. Lai, C. I. Kuan, C. K. Chou, J. M. Wang, H. Y. Tu, H. T. Hu, C. S. Lin, W. J. Wu, Y. S. Pu, E. Sterneck, A. M. Huang, Transcriptional up-regulation of SOD1 by CEBPD: A potential target for cisplatin resistant human urothelial carcinoma cells. Biochem. Pharmacol. 80, 325-334 (2010).
40. E. Sterneck, R. Paylor, V. Jackson-Lewis, M. Libbey, S. Przedborski, L. Tessarollo, J. N. Crawley, P. F. Johnson, Selectively enhanced contextual fear conditioning in mice lacking the transcriptional regulator CCAAT/enhancer binding proteind. Proc. Natl. Acad. Sci. U.S.A. 95, 10908-10913 (1998). (Pubitemid 28413167)
41. J. M. Wang, J. T. Tseng, W. C. Chang, Induction of human NF-IL6b by epidermal growth factor is mediated through the p38 signaling pathway and cAMP response element-binding protein activation in A431 cells. Mol. Biol. Cell 16, 3365-3376 (2005). (Pubitemid 40962605)
42. H. C. Tai, H. Y. Huang, S. W. Lee, C. Y. Lin, M. J. Sheu, S. L. Chang, L. C. Wu, Y. L. Shiue, W. R. Wu, C. M. Lin, C. F. Li, Associations of Rsf-1 overexpression with poor therapeutic response and worse survival in patients with nasopharyngeal carcinoma. J. Clin. Pathol. 65, 248-253 (2012).